Bioceltix Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BCX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies256,8325.22%
Individual Insiders365,7637.43%
VC/PE Firms470,9539.56%
Institutions908,92918.5%
General Public2,921,99159.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.3%.


Top Shareholders

Top 10 shareholders own 40.66% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.56%
Kvarko ASI Sp. z o. o.
470,953zł34.9m0%no data
7.51%
IPOPEMA Towarzystwo Funduszy Inwestycyjnych SA
370,000zł27.4m0%4.83%
7.43%
Lukasz Bzdzion
365,763zł27.1m0%no data
5.22%
Alternative Solution Alternatywna Spolka Inwestycyjna Spolka Akcyjna
256,832zł19.0m0%no data
4.2%
Esaliens TFI S.A.
206,939zł15.3m0%0.86%
3.89%
Towarzystwo Funduszy Inwestycyjnych PZU SA
191,529zł14.2m0%0.2%
2.09%
Norges Bank Investment Management
102,892zł7.6m0%no data
0.36%
Union Investment TFI S.A
17,848zł1.3m0%0.08%
0.24%
Goldman Sachs Asset Management, L.P.
12,000zł888.0k0%no data
0.16%
AgioFunds Towarzystwo Funduszy Inwestycyjnych S.A.
7,721zł571.4k0%0.03%